Thai FDA Confirms Sufficient Methadone Supply for FY 2070 Following Urgent Meeting

Key summary

On October 14, 2569 (2026), the Thai Food and Drug Administration (FDA) convened an urgent Zoom meeting with the National Institute of Mental Health (NIMH), the Ministry of Public Health, and hospitals nationwide to outline strategies for managing methadone supplies. Deputy FDA Director Dr. Rungritai Muangprasit confirmed that Methadone concentrate solution will be available in sufficient quantities throughout the fiscal year 2070. The FDA has already procured raw materials (Methadone powder) for production in FY 2070, instructing the Pharmaceutical Organization (PO) to purchase directly from the FDA for speed. Smart Forecasting systems and a Contract Monitoring Framework are being used to manage procurement and inventory, with a target reserve stock of 4-5 months. The FDA pledged to work closely with hospitals to ensure legal compliance and meet demand.